SCHEMBL29531669

CC(=O)NCSC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(C)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.68

Predicted protein targets (top 3)

	gene	UniProt	supporting neighbours	confidence
▸	IL23R	Q5VWK5	11/20	0.68

▸	GLP1R	P43220	8/20	0.61

▸	GIPR	P48546	8/20	0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30001569	0.96	IL23R (0.71)	IL23R
SCHEMBL29713985	0.94	IL23R (0.68)	IL23RGLP1RGIPR
SCHEMBL29531957	0.90	IL23R (0.66)	IL23RGLP1RGIPR
SCHEMBL13282782	0.89	CXCL8 (0.62)	IL23R
SCHEMBL29500420	0.84	IL23R (0.68)	IL23RGLP1RGIPR
SCHEMBL30658375	0.83	GLP1R (0.68)	GLP1RGIPR
SCHEMBL30415354	0.82	CXCR4 (0.67)	IL23RGLP1R
SCHEMBL30041162	0.82	CALCA (0.64)	GLP1RGIPR
SCHEMBL30973903	0.82	NPY1R (0.66)	IL23RGLP1RGIPR
SCHEMBL31519858	0.82	IL23R (0.72)	IL23RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3395373-B1	METHOD FOR LABELLING A BIOLOGICAL TARGETING MOLECULE VIA CONJUGATION WITH A RADIOISOTOPE SUITABLE FOR PET OR SPECT IMAGING	GE HEALTHCARE LTD (GB)	2022-10-19	—	—	EP	disclosed
US-20220202965-A1	RADIOTRACER COMPOSITIONS AND METHODS	GE HEALTHCARE LTD (GB)	2022-06-30	—	—	US	disclosed
US-11311636-B2	Radiotracer compositions and methods	GE HEALTHCARE LIMITED (GB)	2022-04-26	—	—	US	disclosed
CN-114222592-A	Compounds and methods of use	爱丁堡分子成像有限公司	2022-03-22	—	—	CN	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220202965-A1	RADIOTRACER COMPOSITIONS AND METHODS	MET, METTL14, MEN1	IL23R 2159/4885GLP1R 79/4885GIPR 77/4885
US-11311636-B2	Radiotracer compositions and methods	MET, METTL14, MEN1	IL23R 2159/4885GLP1R 79/4885GIPR 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.